Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 90 | 1 | 11 | 0 | €979.40 | €1,064.7 | 8.708% |
| Boston Scientific | 77 | 0 | 11 | 0 | €39.23 | €83.22 | 112.137% |
| UnitedHealth Group Inc. | 77 | 3 | 13 | 0 | €363.40 | €369.41 | 1.655% |
| Abbott Laboratories | 69 | 0 | 10 | 0 | €91.18 | €114.37 | 25.434% |
| Gilead Sciences Inc | 65 | 0 | 5 | 0 | €112.36 | €128.14 | 14.048% |
| Ionis Pharmaceuticals Inc. | 64 | 1 | 10 | 0 | €47.50 | €79.22 | 66.780% |
| Insmed Inc. | 63 | 1 | 4 | 0 | €87.50 | €173.11 | 97.845% |
| Neurocrine Bioscience | 59 | 0 | 7 | 0 | €143.65 | €155.28 | 8.098% |
| Insulet Corp. | 60 | 1 | 3 | 0 | €143.75 | €305.21 | 112.319% |
| Johnson & Johnson | 56 | 0 | 12 | 0 | €221.85 | €227.33 | 2.468% |
| HCA Holdings Inc. | 55 | 2 | 8 | 2 | €344.60 | €435.61 | 26.412% |
| Dexcom Inc. | 54 | 2 | 5 | 0 | €71.80 | €75.24 | 4.793% |
| Alnylam Pharmace. | 47 | 0 | 7 | 0 | €178.00 | €429.93 | 141.534% |
| Vertex Pharmaceuticals Inc. | 47 | 1 | 3 | 1 | €412.35 | €467.05 | 13.265% |
| Regeneron Pharmaceuticals Inc. | 45 | 0 | 6 | 0 | €641.40 | €728.50 | 13.580% |
| Tenet Healthcare | 44 | 0 | 12 | 0 | €220.00 | €217.45 | -1.159% |
| AbbVie Inc. | 43 | 0 | 10 | 0 | €219.30 | €228.85 | 4.356% |
| Biogen Inc. | 43 | 1 | 10 | 1 | €178.62 | €200.07 | 12.006% |
| Jazz Pharmaceuticals plc | 41 | 0 | 5 | 0 | €224.20 | €224.09 | -0.051% |
| Cytokinetics Inc. | 41 | 0 | 0 | 0 | €69.76 | €81.13 | 16.299% |
| Medtronic plc | 41 | 1 | 2 | 0 | €73.56 | €97.41 | 32.416% |
| Rhythm Pharmaceuticals | 36 | 1 | 2 | 0 | €91.50 | €116.89 | 27.747% |
| Amgen Inc. | 36 | 2 | 2 | 0 | €332.90 | €332.22 | -0.205% |
| Agilent Technologies Inc. | 33 | 0 | 0 | 0 | €120.30 | €137.44 | 14.248% |
| Cigna Corp. | 32 | 0 | 0 | 0 | €252.10 | €288.04 | 14.256% |